bio event
Research , LV Prasad Eye Institute .
The second half of the day saw a panel discussion on “ Patent protection and value of Innovation and R & D ” wherein the panelists discussed on how pharma companies should innovate and come up with new drugs , patent protection and also on the additional investments being taken by the pharma companies to meet their goals . Simultaneously , another panel discussion on the topic “ Existing ecosystem & way forward of Automation in Government , Semi- Government , Private , Corporate , Standalone , PHCs , Rural Health Centres & Diagnostic Services ” was held .
Speaking on the success of second day of the event , Mr Shakthi Nagappan , CEO , BioAsia said , “ The second day of Bio Asia was focused on innovation required in medical & life sciences and how automation can play a significant role in diagnostics . The CEO Conclave , with a very eminent panel , also deliberated on the significant role which Indian Life Sciences Industry can play in ensuring appropriate treatment to a billion patients . We have got a tremendous response for the sessions and panel discussions as we saw encouraging participation . It was an enriching experience for us all as the industry experts shared their opinions on the respective topics .”
Novartis signed an MoU with National Institute of
Pharmaceutical Education and Research ( NIPER ) Hyderabad in building capabilities and skills . Mr . Glenn Saldanha , Chairman and Managing Director , Glenmark Pharmaceuticals Ltd ., India was impressed with the infrastructure , environment and progressive approach of the Telangana
State Government .
Innovation is the new buzzword
The last day of the event started with the key note session of Mr Narayana Murthy , Founder , Infosys . He said , “ India has made tremendous strides in improving Health indicator in the last few
Dr Vasanth Narasimhan , Global Head of Drug Development & CMO , Novartis , Switzerland signing an MoU with NIPER Hyderabad in the presence of Mr K T Rama Rao , Minister for Industries & Commerce , IT E & S , MAUD , Government of Telangana on the sidelines of BioAsia 2017 .
years . If we take the case of vaccine development , science and technology has a significant role to play and has already contributed in India itself with examples like the development of vaccine for Rotavirus . However , there are huge disparities between the states in India with some of them in the southern states
28 BioVoiceNews | March 2017